July 18, 2018 / 5:13 AM / 4 months ago

BRIEF-Cassiopea H1 Loss After Taxes At EUR 6.7 Mln

July 18 (Reuters) - CASSIOPEA SPA:

* VERY POSITIVE TOP LINE PHASE III RESULTS FOR WINLEVI(R) (CLASCOTERONE) IN TREATING ACNE

* VERY POSITIVE SIX-MONTH INTERIM ANALYSIS PHASE II DOSE RANGING RESULTS FOR BREEZULA(R) (CLASCOTERONE) IN TREATING ANDROGENETIC ALOPECIA IN MEN

* H1 LOSS AFTER TAXES AT EUR 6.7 MILLION VERSUS LOSS OF EUR 9.3 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below